Genomics and Precision Medicine: Molecular Diagnostics Innovations Shaping the Future of Healthcare in Qatar

• Published in: Advances in Public Health Vol. 2019; no. 2019; pp. 1 - 11
• Main Authors: AL-Dewik, Nader I., Qoronfleh, M. Walid
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 30.04.2019; Hindawi; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Biotechnology industry; Diagnostic equipment (Medical); Evidence-based medicine; Gene expression; Genes; Genomes; Health care reform; Innovations; Pharmacogenetics; Saudi Arabia; Qatar; United Arab Emirates
• ISSN: 2356-6868; 2314-7784
• DOI: 10.1155/2019/3807032

Unprecedented developments in genomics research and ancillary technologies are creating the potential for astonishing changes in both the healthcare field and the life sciences sector. The innovative genomics applications include the following: (1) embracing next generation sequencing (NGS) in clinical diagnostics setting (applying both whole genome and exome sequencing), (2) single cell sequencing studies, (3) quantifying gene expression changes (including whole transcriptome sequencing), (4) pharmacogenomics, and (5) cell-free DNA blood-based testing. This minireview describes the impact of clinical genomics disruptive innovations on the healthcare system in order to provide better diagnosis and treatment. The observed evolution is not limited to the point-of-care services. Genomics technological breakthroughs are pushing the healthcare environment towards personalized healthcare with the real potential to attain better wellbeing. In this article, we will briefly discuss the Gulf region population-based genome initiatives that intend to improve personalized healthcare by offering better prevention, diagnosis, and therapy for the individual (precision medicine). Qatar’s endeavor in genomics medicine will be underscored including the private Applied Biomedicine Initiative (ABI).